Post-surgery adjuvant therapy with intermediate doses of interferon alfa 2b versus observation in patients with stage IIb/III melanoma (EORTC 18952): Randomised controlled trial
- Alexander M.M. Eggermont
- , Stefan Suciu
- , Rona MacKie
- , Wlodzimierz Ruka
- , Alessandro Testori
- , Wim Kruit
- , Cornelis J.A. Punt
- , Michelle Delauney
- , François Sales
- , Gerard Groenewegen
- , Dirk J. Ruiter
- , Izabella Jagiello
- , Konstantin Stoitchkov
- , Ulrich Keilholz
- , Danielle Lienard
Research output: Contribution to journal › Article › peer-review
309
Citations
(Scopus)